HUTCHMED (China) (HCM) Net Income towards Common Stockholders (2015 - 2021)

HUTCHMED (China) (HCM) reported Net Income towards Common Stockholders of -$77.6 million for Q2 2021, down 551.86% year-over-year from $17.2 million in Q2 2020, and down 27.31% quarter-over-quarter from -$61.0 million in Q1 2021.

HUTCHMED (China) (HCM) Net Income towards Common Stockholders (2015 - 2021) Analysis & Trends

HUTCHMED (China) (HCM) has 6 years of Net Income towards Common Stockholders data on file, last reported at -$77.6 million in Q2 2021.

  • Net Income towards Common Stockholders for Q2 2021 came in at -$77.6 million, down 551.86% year-over-year; the trailing twelve-month figure through Dec 2022 was -$77.6 million (up 43.99% YoY), and the FY2025 annual result was $64.4 million, up 8132.64% from the prior year.
  • Net Income towards Common Stockholders retreated to -$77.6 million in Q2 2021 per HCM's latest filing, from -$61.0 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at $70.1 million in Q2 2018 and troughed at -$99.4 million in Q2 2019.
  • A 4-year average of -$17.2 million and a median of -$26.3 million in 2018 frame the typical range for Net Income towards Common Stockholders.
  • The sharpest annual moves came in 2019 and 2021: Net Income towards Common Stockholders jumped 250.63% in 2019, then sank 551.86% in 2021.
  • A 4-year view of Net Income towards Common Stockholders shows it stood at $22.1 million in 2018, then tumbled by 270.87% to -$37.8 million in 2019, then jumped by 145.5% to $17.2 million in 2020, then slumped by 551.86% to -$77.6 million in 2021.
  • Business Quant data shows HCM's Net Income towards Common Stockholders at -$77.6 million in Q2 2021, -$61.0 million in Q1 2021, and $17.2 million in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 366.00 Mn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn 1.99 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -66.53 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 118.42 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn -92.12 Mn
10 HUTCHMED (China) 1.20 Bn -269.38 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2021 -77.62 Mn
Mar 31, 2021 -60.97 Mn
Jun 30, 2020 17.18 Mn
Mar 31, 2020 -30.28 Mn
Dec 31, 2019 -37.75 Mn
Sep 30, 2019 -34.24 Mn
Jun 30, 2019 -99.44 Mn
Mar 31, 2019 33.60 Mn
Dec 31, 2018 22.09 Mn
Sep 30, 2018 12.78 Mn
Jun 30, 2018 70.12 Mn
Mar 31, 2018 -22.31 Mn
Jun 30, 2016 85.09 Mn
Jun 30, 2015 70.55 Mn